Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Stimulating the Resolution of Inflammation Through Omega-3 Polyunsaturated Fatty Acids in COVID-19: Rationale for the COVID-Omega-F Trial
Authors
Keywords
-
Journal
Frontiers in Physiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-13
DOI
10.3389/fphys.2020.624657
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Leukotriene Receptor Antagonist Montelukast as a Potential COVID-19 Therapeutic
- (2021) Ludwig Aigner et al. Frontiers in Molecular Biosciences
- Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
- (2020) Qiurong Ruan et al. INTENSIVE CARE MEDICINE
- Inflammation and its resolution in coronary artery disease: a tightrope walk between omega-6 and omega-3 polyunsaturated fatty acids
- (2020) Gonzalo Artiach et al. Kardiologia Polska
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
- (2020) Chaolin Huang et al. LANCET
- Inflammation resolution: a dual-pronged approach to averting cytokine storms in COVID-19?
- (2020) Dipak Panigrahy et al. CANCER AND METASTASIS REVIEWS
- Clinical and immunological features of severe and moderate coronavirus disease 2019
- (2020) Guang Chen et al. JOURNAL OF CLINICAL INVESTIGATION
- COVID-19 illness in native and immunosuppressed states: A clinical–therapeutic staging proposal
- (2020) Hasan K. Siddiqi et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
- (2020) Mingfeng Liao et al. NATURE MEDICINE
- Misguided drug advice for COVID-19
- (2020) Garret A. FitzGerald SCIENCE
- Eicosanoids
- (2020) Bruce D. Hammock et al. AMERICAN JOURNAL OF PATHOLOGY
- Endothelial dysfunction in COVID-19: a position paper of the ESC Working Group for Atherosclerosis and Vascular Biology, and the ESC Council of Basic Cardiovascular Science
- (2020) Paul C Evans et al. CARDIOVASCULAR RESEARCH
- Omega-3 Polyunsaturated Fatty Acids Decrease Aortic Valve Disease through the Resolvin E1 and ChemR23 Axis
- (2020) Gonzalo Artiach et al. CIRCULATION
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- A single-cell atlas of the peripheral immune response in patients with severe COVID-19
- (2020) Aaron J. Wilk et al. NATURE MEDICINE
- Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Exploration of n-6 and n-3 Polyunsaturated Fatty Acids Metabolites Associated with Nutritional Levels in Patients with Severe Stable Chronic Obstructive Pulmonary Disease
- (2020) Mingshan Xue et al. International Journal of Chronic Obstructive Pulmonary Disease
- The COVID-19 Cytokine Storm; What We Know So Far
- (2020) Dina Ragab et al. Frontiers in Immunology
- Dexamethasone, pro‐resolving lipid mediators and resolution of inflammation in COVID‐19
- (2020) Evangelos Andreakos et al. ALLERGY
- Specialized pro-resolving mediator network: an update on production and actions
- (2020) Nan Chiang et al. Essays in Biochemistry
- Cytokine Levels in Critically Ill Patients With COVID-19 and Other Conditions
- (2020) Matthijs Kox et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Anti-Inflammatory and Proresolving Effects of the Omega-6 Polyunsaturated Fatty Acid Adrenic Acid
- (2020) Hilde Brouwers et al. JOURNAL OF IMMUNOLOGY
- Age, Frailty, and Comorbidity as Prognostic Factors for Short-Term Outcomes in Patients With Coronavirus Disease 2019 in Geriatric Care
- (2020) Sara Hägg et al. Journal of the American Medical Directors Association
- Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?
- (2020) Ahmed M. Darwesh et al. PHARMACOLOGY & THERAPEUTICS
- Parenteral fish oil: An adjuvant pharmacotherapy for coronavirus disease 2019?
- (2020) Raquel S. Torrinhas et al. NUTRITION
- ERV1/ChemR23 Signaling Protects from Atherosclerosis by Modifying oxLDL Uptake and Phagocytosis in Macrophages
- (2018) Andres Laguna-Fernandez et al. CIRCULATION
- Dexamethasone induces ω3-derived immunoresolvents driving resolution of allergic airway inflammation
- (2018) Katerina Pyrillou et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia
- (2018) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Omega-3 Polyunsaturated Fatty Acids in Critically Ill Patients with Acute Respiratory Distress Syndrome: A Systematic Review and Meta-analysis
- (2018) Pascal L. Langlois et al. NUTRITION
- Low salivary resolvin D1 to leukotriene B4 ratio predicts carotid intima media thickness: A novel biomarker of non-resolving vascular inflammation
- (2017) Silke Thul et al. European Journal of Preventive Cardiology
- DHA- and EPA-derived resolvins, protectins, and maresins in airway inflammation
- (2016) Melody G. Duvall et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling
- (2016) Tarec K. Elajami et al. FASEB JOURNAL
- Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7
- (2014) Magnus Bäck et al. BRITISH JOURNAL OF PHARMACOLOGY
- Aging Delays Resolution of Acute Inflammation in Mice: Reprogramming the Host Response with Novel Nano-Proresolving Medicines
- (2014) Hildur H. Arnardottir et al. JOURNAL OF IMMUNOLOGY
- Pro-resolving lipid mediators are leads for resolution physiology
- (2014) Charles N. Serhan NATURE
- The Lipid Mediator Protectin D1 Inhibits Influenza Virus Replication and Improves Severe Influenza
- (2013) Masayuki Morita et al. CELL
- Nationwide cohort study of the leukotriene receptor antagonist montelukast and incident or recurrent cardiovascular disease
- (2012) Erik Ingelsson et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Fish oil supplementation in the parenteral nutrition of critically ill medical patients: a randomised controlled trial
- (2008) Sigrun Friesecke et al. INTENSIVE CARE MEDICINE
- Effects on hemodynamics and gas exchange of omega-3 fatty acid-enriched lipid emulsion in acute respiratory distress syndrome (ARDS): a prospective, randomized, double-blind, parallel group study
- (2008) Joan Sabater et al. Lipids in Health and Disease
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search